CLO26-123: Genomic Adjusted Radiation Dose (GARD) Predicts Optimal Radiation Dose for Overall Survival in Triple-Negative Breast Cancer.

Saved in:
Bibliographic Details
Title: CLO26-123: Genomic Adjusted Radiation Dose (GARD) Predicts Optimal Radiation Dose for Overall Survival in Triple-Negative Breast Cancer.
Authors: Nellore S; 1Case Western Reserve University, Cleveland, OH., Ho E; 2Penn Medicine, Philadelphia, PA., Joshi N; 1Case Western Reserve University, Cleveland, OH., Chen P; 1Case Western Reserve University, Cleveland, OH., Nowacki A; 1Case Western Reserve University, Cleveland, OH., Torres-Roca J; 3Moffitt Cancer Center, Tampa, FL., Scott J; 1Case Western Reserve University, Cleveland, OH.
Source: Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2026 Mar 31; Vol. 24 (3.5). Date of Electronic Publication: 2026 Mar 31.
Publication Type: Journal Article
Journal Info: Publisher: Harborside Press Country of Publication: United States NLM ID: 101162515 Publication Model: Electronic Cited Medium: Internet ISSN: 1540-1413 (Electronic) Linking ISSN: 15401405 NLM ISO Abbreviation: J Natl Compr Canc Netw Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:1540-1413
DOI:10.6004/jnccn.2025.7252